您要查找的是不是:
- Fibrous autoimmune thyroiditis 纤维性自身免疫性甲状腺炎
- Methods The clinical and pathological changes of 89 cases of autoimmune thyroiditis were reviewed and analysed. 方法回顾性分析89例自身免疫性甲状腺炎的临床表现,病理变化。
- Objective To investigate the role of interferon regulatory factor(IRF)-1 in the development of experimental autoimmune thyroiditis(EAT). 目的 探讨干扰素调节因子 (IRF) 1在实验性自发免疫性甲状腺炎 (EAT)发病及进展过程中的作用。
- Methods: Wistar rats were divided into three groups:normal control,experimental autoimmune thyroiditis (EAT) group and selenium cura- tio-EAT group. 方法:Wistar大鼠分为对照组、自身免疫性甲状腺炎(EAT)组和硒治疗EAT组。
- If treatment is not absolutely necessary, the patients with signs of autoimmune thyroiditis should not be treated for hepatitis C. 如果治疗不是特别必要的话,甲状腺免疫标志物阳性的丙肝患者应该不进行治疗。
- Systemic lupus erythematosus( SLE) and autoimmune thyroid diseases are both marked by pathogenic autoantibodies. 摘要病理性自体抗体在全身性红斑狼疮及自体免疫性甲状腺疾病都扮演重要角色。
- Systemic lupus erythematosus (SLE) and autoimmune thyroid diseases are both marked by pathogenic autoantibodies. 摘要病理性自体抗体在全身性红斑狼疮及自体免疫性甲状腺疾病都扮演重要角色。
- Pyne D, Isenberg DA. Autoimmune thyroid disease in systemic lupus erythematosus[J]. Ann Rheum Dis, 2002,61(1):70 72. 张红卫;蒋明;黄英伟;等.;系统性红斑狼疮患者甲状腺功能异常[J]
- Lu FL,Wang SJ,Xu HX,et al.Study on the treatment of experimental autoimmune thyroiditis in mice by dexamethasone[J].Shanghai Mianyixue Zazhi(J Shanghai Immun), 1998,18(1):41-45. [5]陆福履;王胜军;许化溪;等.;地塞米松治疗小鼠实验性自身免疫性甲状腺炎的研究[J]
- Graves' disease is one of the important autoimmune thyroid diseases to cause hyperthyroidism. 摘要葛瑞夫兹氏疾病是造成甲状腺机能亢进之重要甲状腺自体免疫疾病。
- Objective To compare the curative effects between the traditional and new immunosuppressants in autoimmune thyroid ophthalmopathy. 目的对比观察传统与新型免疫抑制剂对自身免疫性甲状腺眼病的疗效。
- The concentrations of Tamm-Horsfall protein (THP)in urine from 72 patients with autoimmune thyroid disease (AITD), 13 patients with non-AITD and 30 healthy were measured by RIA. 作者采用放免分析法检测了自身免疫性甲状腺疾病(AITD)72例患者尿中Tamm-Horsfall(TH)蛋白(THP)的含量;并与非自身免疫性甲状腺疾病(NAITD)患者及正常人作对照.
- At the present a clear account of pathogensis of autoimmune thyroid disease(AITD) cannot be given, although several pathogenic factors have been implicated in AITD. 自身免疫性甲状腺病(AITD)的发病机制尚未完全明了,某些遗传和环境因素可能与AITD发病有关,但在不同个体,不同致病因素所起的作用可能亦不相同。
- Objective The development of experimental autoimmune thyroiditis (EAT) was investigated by immunization of Wistar rats with human thyroglobulin (hTG) , human thyroid peroxidase (hTPO) and guinea pig thyroid stimulating hormone receptor (gTSHR). 目的观察人类甲状腺球蛋白(hTG),人类甲状腺过氧化物酶(hTPO)以及豚鼠促甲状腺激素受体(gTSHR)免疫诱导Wistar大鼠产生实验性自身免疫性甲状腺炎(EAT)的过程。
- Autoimmune thyroid diseases have associated with a number of non-organ-specific rheumatological disorders, including SLE, Sj? gren's syndrome, giant cell arteritis, and rheumatoid arthritis. 自体免疫性甲状腺疾病与很多非器官性的风湿免疫疾病有关,这包括全身性红斑狼疮、格兰氏症候群、细胞性动脉炎、风湿性关节炎。
- The value of ultrasturctrual pathology in differentiating autoimmune thyroid diseases (AITD) was also studied in some cases. Of 57 CNB cases, 52 (91. 2% ) samples were adequate for histologic diagnosis. 结果显示活极成功率为93.;0%25,病理诊断率91
- HLA DR expression in autoimmune thyroid diseases was in the membrane, and in non autoimmune thyroid and it was restricted to the cytoplasm. There was significant difference between them(P<0.05). 在自身免疫性甲状腺疾病中 ;HLA DR抗原的表达主要在细胞膜 ;而在非自身免疫性甲状腺疾病中 ;HLA DR抗原的表达多局限于细胞浆 ;二者之间存在显著差异 (P <0 .;0 5 )。
- Iodine excess tends to induce or aggravate the occurrence and development of autoimmune thyroid diseases (AITD),which has been demonstrated by epidemiological investigation and animal models. 碘摄入过多可诱发或加重自身免疫性甲状腺疾病(AITD)的发生、进展,这在流行病学调查和动物模型中均得到了证实。
- New topics include the clinical relevance of the sodium/iodide symporter (NIS), broad coverage of autoimmune thyroid disease, and expanded coverage of thyroid cancer, including recombinant human TSH. 其他章在怀孕和产后,甲状腺孩子和老年人和评估和结节的甲状腺肿的管理的疾病期间讨论甲状腺机能失调。
- A single nucleotide polymorphism (SNP) in the PTPN22 gene known as +1858C>T was recently reported to be associated with several autoimmune diseases including autoimmune thyroid disease (AITD). 最近报道该基因的+1858C>T单核苷酸多态性(SNP)与多种自身免疫性疾病相关,其中包括自身免疫性甲状腺病(AITD)。